when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

pharmadog news

Browse

1,129 stories matching this filter · ← front page

★ save view ↓export CSV

rangeto

sort

recent oldest source alpha

source

STAT829 Endpoints632 BioPharma Dive241 onclive165 Fierce Biotech92 BioSpace91 raps37 globenewswire health28

therapy area

all Oncology4988 Rare Disease819 Hematology759 Cardiology717 Immunology715 Psychiatry & CNS579 Pulmonology

Opinion: Beware the unintended consequences of testosterone screening for military servicemembers
“I fear that the widespread rollout of testosterone screening may lead to some surprising and unintended consequences,” writes a urologist who studies testosterone.
STAT · 12d ago↗ source
Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) Issues Voluntary Nationwide Recall of Cetirizine Hydrochloride Tablets USP 5 mg Due to Potential Cross Contamination with Ranitidine
FOR IMMEDIATE RELEASE – July 18th, 2026 – Panoli, Gujarat, Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) is voluntarily recalling four lots of Cetirizine Hyd…
fda recalls · 12d ago↗ source
Opinion: STAT readers on the value of primary care, obesity as a disease, and more

page 9 of 46

570

Endocrinology & Metabolism288

Ophthalmology254

Infectious Disease238

“The real opportunity is to move beyond policies and narratives that pit specialties against one another,” presidents of the AAFP, ACP, and AAP write.

STAT · 13d ago↗ source

Fayus Inc., dba Yusol International Foods Expands Recall of OLA-OLA POUNDED YAM Due to Undeclared Milk Allergen

Fayus Inc., doing business as Yusol International Foods (Sacramento, CA) is expanding its recall of OLA-OLA POUNDED YAM to include product sizes 2lbs, 4lbs, 5lbs, and 10lbs due to product labeling…

fda recalls · 13d ago↗ source

Opinion: What the 20th-century war on smog tells us about today’s wildfire smoke

The evolution of air pollution policy shows how to respond to the dangerous haze caused by Canadian wildfires, experts write in opinion piece.

STAT · 13d ago↗ source

Quitting smoking is hard. A Medicare change may push doctors to give more help

Physicians who offer counseling on quitting cigarettes and alcohol during patient visits would get a 19% increase in reimbursement under a proposed Medicare change.

STAT · 13d ago↗ source

Jasper gets a lifeline in merger with immune drugmaker Kira

The acquisition, which involves a concurrent licensing deal with startup Mirador, gives Jasper a chance to rebound from setbacks that have wiped out most of its market value.

BioPharma Dive · 13d ago↗ source

Lettuce at Taco Bell in five states confirmed as a source of diarrhea-causing parasite

Health officials have identified lettuce from Mexico served at Taco Bell locations across five U.S. states as a source of the outbreak of diarrhea-causing parasite cyclospora.

STAT · 13d ago↗ source

STAT+: The end for GSK’s chronic cough treatment

Sonothera's ultrasound gene therapy delivery, a new Alzheimer's drug controversy, and more biotech news from The Readout

STAT · 13d ago↗ source

Arbutus, Sanofi escalate mRNA patent fights; InnoCare’s TYK2 contender advances

The new lawsuits add to a web of legal disputes over technology involved in COVID vaccines. Elsewhere, a prolific AI biotech inked another deal and Insmed strengthened support for a closely watched…

BioPharma Dive · 13d ago↗ source

Compounders maintain a firm grip on the GLP-1 market

Despite an FDA crackdown, numerous pharma lawsuits and possible safety risks, nearly 1 in 5 patients are still taking cheaper weight-loss alternatives.

BioPharma Dive · 13d ago↗ source

GSK shelves cough drug acquired in $2B deal

Mixed Phase 3 data for camlipixant prompted the British pharma to cease development, making the drug the third from its class to fail.

BioPharma Dive · 13d ago↗ source

STAT+: Up and down the ladder: The latest comings and goings

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

STAT · 13d ago↗ source

STAT+: Pharmalittle: We’re reading about rising drug shortages, GSK coughing up a trial loss, and more

The number of active medication shortages in the U.S. rose to 227 in the second quarter of 2026

STAT · 13d ago↗ source

How well are AI-discovered drugs faring in the clinic?

Some of the industry’s most closely-watched AI drugs could provide insight into the success of technology-assisted development.

BioPharma Dive · 13d ago↗ source

Who can access testosterone hormone medication in the U.S.?

Wildfire smoke health hazards, a new idea for treating Duchenne, and more health news from Morning Rounds

STAT · 13d ago↗ source

STAT+: Can ultrasound unlock the power of gene therapy? A startup makes big claims

Sonothera is developing a new way to deliver genes into cells that, if borne out, could have a big impact on muscular dystrophy and other diseases.

STAT · 14d ago↗ source

Opinion: MAHA is rewriting the vocabulary of American mental health care

“‘Deprescribing’ elevated into a movement, and a cultural default, is a clinical hazard,” writes Sunny Patel.

STAT · 14d ago↗ source

STAT+: MDCalc is scoring the clinical calculators used by millions of doctors

MDCalc is launching a quality-rating system for the more than 800 clinical calculators used to assess disease risk, transplant eligibility, and more.

STAT · 14d ago↗ source

Why affirming trans identities can be critical for suicide prevention counseling

Advocates worry that excluding trans youth in some way from LGBTQ+ counseling services provided through the 988 crisis line could be harmful.

STAT · 14d ago↗ source

Taylor Fresh Foods Recalls Iceberg Lettuce from Central Mexico Because of Possible Health Risk

Taylor Farms de Mexico of Guanajuato, Mexico is voluntarily removing all iceberg lettuce sourced from central Mexico from the U.S. market, because it has the potential to be contaminated with Cyclo…

fda recalls · 14d ago↗ source

Experts: Ending adequate provision would shut down prescription drug ads

The US Food and Drug Administration’s (FDA) plans to eliminate adequate provision in direct-to-consumer (DTC) prescription drug ads could result in a de facto ban on drug advertising due to the hig…

raps · 14d ago↗ source

Industry wants more clarity on NGS for assessing gene therapy safety

The pharmaceutical industry has largely endorsed the US Food and Drug Administration's (FDA) guidance on next-generation sequencing (NGS) for assessing the safety of human gene therapy products. Ho…

raps · 14d ago↗ source

This Week at FDA: FDA staff raise concerns about peptide conflicts, top Democrat wants DOGE investigation, and more

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This wee…

raps · 14d ago↗ source

Khong Guan Corporation Issues Recall of Glutinous Rice Balls With Black Sesame Filling Due to Undeclared Peanuts

Khong Guan Corporation is recalling specific lots of “Glutinous Rice Balls with Black Sesame Filling” because they may contain undeclared peanuts. People who have an allergy or severe sensitivity t…

fda recalls · 14d ago↗ source